Charles P. Dolan
CIK: 0001496956
Associated companies
this person other insiders at MSGE
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Knicks' role in Foot Locker's turnaround discussed. Recent coverage examines how the New York Knicks may support Foot Locker's efforts to improve its business performance. This is relevant to Madison Square Garden Sports Corp. because the Knicks are a major asset within the MSGS portfolio. While the news focuses on a partner's strategy, it highlights the broader commercial ecosystem surrounding the team.
this person other insiders at MSGS
Transaction History
| MSGE | ▼ Sell | Open Market | 19,311 | $1.2M | 2/20/2026 | View on chart |
| MSGS | ▼ Sell | Open Market | 331 | $108K | 2/20/2026 | View on chart |
| MSGS | ▼ Sell | Open Market | 4,057 | $1.3M | 2/20/2026 | View on chart |
| MSGS | ▼ Sell | Open Market | 1,271 | $414K | 2/20/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
MSGE Eyes Strong Q1 Earnings, Potential Re-Rating
Analysts anticipate robust first‑quarter results for Madison Square Garden Entertainment, which could prompt a re‑rating of the stock. The company sits near a neutral RSI and a key support level around $75.96, within its 52‑week range. A positive earnings surprise may lift the share toward its analyst target of $91.62.
MSGE Eyes Strong Q1 Earnings, Potential Re-Rating. Analysts anticipate robust first‑quarter results for Madison Square Garden Entertainment, which could prompt a re‑rating of the stock. The company sits near a neutral RSI and a key support level around $75.96, within its 52‑week range. A positive earnings surprise may lift the share toward its analyst target of $91.62.